Agios Pharmaceuticals
Latest round
- Series C
Last raised
- Nov 2011
Total raised
- $120M
Investors
- 5
About Agios Pharmaceuticals
Agios Pharmaceuticals, Inc.Founded in 2007 and headquartered in Cambridge, US, Agios Pharmaceuticals focuses on advancing therapies for rare diseases.8 billion, which was finalized in April 2021.Agios Pharmaceuticals specializes in pioneering therapies for rare diseases, particularly in cellular metabolism. Its primary product, PYRUKYND® (mitapivat), is approved for adults with pyruvate kinase deficiency, a rare form of hemolytic anemia. The company is also developing AG-946, an investigational PK activator, targeting various hemolytic anemias.50 mn, stemming primarily from its flagship product, PYRUKYND®. The company generates revenue through partnerships with healthcare providers and specialty pharmacies that facilitate access to its therapies.Agios Pharmaceuticals is focused on launching additional products and expanding its market presence. Following its recent acquisition, the company aims to enhance its offerings in malignant hematology and potentially enter the solid tumor market.
Who invested in Agios Pharmaceuticals
5 investors across 5 rounds
See all investors in Agios Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Agios Pharmaceuticals
Who invested in Agios Pharmaceuticals?
Agios Pharmaceuticals has 5 investors on record across 5 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Agios Pharmaceuticals raised?
Agios Pharmaceuticals has raised 5 venture rounds. Sign up free to see how much each round raised and the total.
When did Agios Pharmaceuticals last raise money?
Agios Pharmaceuticals's most recent round on record is a Series C, in Nov 2011.
What does Agios Pharmaceuticals do?
Agios Pharmaceuticals is a pharmaceuticals company.
Where is Agios Pharmaceuticals headquartered?
Agios Pharmaceuticals is headquartered in Cambridge, US.
Which VCs invest in companies like Agios Pharmaceuticals?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Agios Pharmaceuticals's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series C
Raising like Agios Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.